Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,061 | 9,410 | 2,139 | 8,714 | 7,753 |
| Other current assets | 77 | 82 | 120 | 256 | 624 |
| TOTAL | $22,649 | $11,081 | $3,607 | $10,659 | $10,012 |
| Non-Current Assets | |||||
| PPE Net | 384 | 432 | 482 | 543 | 614 |
| Other Non-Current Assets | 3,963 | 4,111 | 4,253 | 4,389 | 4,520 |
| TOTAL | $4,347 | $4,543 | $4,735 | $4,932 | $5,134 |
| Total Assets | $26,996 | $15,624 | $8,342 | $15,591 | $15,146 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,219 | 2,903 | 3,789 | 3,053 | 3,532 |
| Accrued Expenses | 1,901 | 1,040 | 472 | 1,856 | 922 |
| Other current liabilities | 1,494 | 948 | 1,132 | 1,298 | 1,428 |
| TOTAL | $5,614 | $4,891 | $5,393 | $6,207 | $5,882 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,990 | 4,209 | 4,422 | 4,629 | 4,844 |
| TOTAL | $3,990 | $4,209 | $4,422 | $4,629 | $4,844 |
| Total Liabilities | $9,604 | $9,100 | $9,815 | $10,836 | $10,726 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,850 | 3,288 | 405 | 73 | 26 |
| Common Shares | 110 | 99 | 84 | 84 | 82 |
| Retained earnings | -269,217 | -260,189 | -253,985 | -247,577 | -241,265 |
| TOTAL | $17,392 | $6,524 | $-1,473 | $4,755 | $4,420 |
| Total Liabilities And Equity | $26,996 | $15,624 | $8,342 | $15,591 | $15,146 |